Ovarian cancer standard of care has not advanced in over 30 years, but a new DNA-based immunotherapy could be a gamechanger, showing major survival gains in clinical trials.

Ovarian cancer is characterized by uncontrolled growth of cells in the ovaries. It can progress to another part of the body ...

Separate facts and misconceptions about ovarian cancer to help better prevent and manage the disease.

Corcept’s overall survival data “look competitive” with AbbVie’s Elahere and Merck’s blockbuster Keytruda, Truist Securities ...

Stage 2 ovarian cancer is localized to the pelvis, with substages 2A and 2B indicating specific spread patterns. Diagnosis involves physical exams, imaging, blood tests, and biopsy to confirm cancer ...

GLP-1 receptor agonists are linked to a 55% reduction in mortality risk in women with ovarian cancer, based on a retrospective cohort study. The study utilized data from the TriNetX Research Network, ...

Differentiating palliative care from hospice is crucial; palliative care focuses on holistic treatment, while hospice ...